Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

1.

Syringotropic mycosis fungoides: Clinical and histologic features, response to treatment, and outcome in 19 patients.

de Masson A, Battistella M, Vignon-Pennamen MD, Cavelier-Balloy B, Mouly F, Rybojad M, Bouaziz JD, Petit A, Saussine A, Ronceray S, Le Gall F, Ram-Wolff C, Assouly P, Dereure O, Joly P, Dallot A, Dupuy A, Lebbé C, Moulonguet I, Rivet J, Janin A, Bagot M.

J Am Acad Dermatol. 2014 Jul 18. pii: S0190-9622(14)01648-X. doi: 10.1016/j.jaad.2014.06.033. [Epub ahead of print]

PMID:
25044343
[PubMed - as supplied by publisher]
2.

Ultrasensitive detection and identification of BRAF V600 mutations in fresh frozen, FFPE, and plasma samples of melanoma patients by E-ice-COLD-PCR.

How-Kit A, Lebbé C, Bousard A, Daunay A, Mazaleyrat N, Daviaud C, Mourah S, Tost J.

Anal Bioanal Chem. 2014 Jun 27. [Epub ahead of print]

PMID:
24969466
[PubMed - as supplied by publisher]
3.

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma.

Lebbé C, How-Kit A, Battistella M, Sadoux A, Podgorniak MP, Sidina I, Pages C, Roux J, Porcher R, Tost J, Mourah S.

Melanoma Res. 2014 Aug;24(4):415-8. doi: 10.1097/CMR.0000000000000088. No abstract available.

PMID:
24933605
[PubMed - in process]
4.

Four cases of rituximab-associated melanoma.

Velter C, Pagès C, Schneider P, Osio A, Brice P, Lebbé C.

Melanoma Res. 2014 Aug;24(4):401-3. doi: 10.1097/CMR.0000000000000074.

PMID:
24743053
[PubMed - in process]
5.

Unresectable Perineal Cuniculatum Carcinoma: Partial Remission Using Systemic Isotretinoin and Interferon-α2a Therapy.

Tauber M, Monsel G, Bonnecarrère L, Battistella M, Cordel N, Honein C, Aubin F, Bagot M, Petit A, Lebbé C, Viguier M.

Acta Derm Venereol. 2014 Mar 25. doi: 10.2340/00015555-1852. [Epub ahead of print]

PMID:
24676771
[PubMed - as supplied by publisher]
Free Article
6.

Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial'.

Bedikian AY, Garbe C, Conry R, Lebbe C, Grob JJ; Genasense Melanoma Study Group.

Melanoma Res. 2014 Jun;24(3):237-43. doi: 10.1097/CMR.0000000000000056.

PMID:
24667300
[PubMed - in process]
7.

French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin.

Bejar C, Basset-Seguin N, Faure F, Fieschi C, Frances C, Guenne C, Lebbe C, Peraldi MN, Roux J, Lamas G, Maubec E; SFORL workgroup.

Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Apr;131(2):121-9. doi: 10.1016/j.anorl.2014.02.002. Epub 2014 Mar 19.

PMID:
24656876
[PubMed - in process]
8.

[Clinical and biological heterogeneity of melanomas].

Delyon J, Mourah S, Lebbé C.

Rev Prat. 2014 Jan;64(1):72-3. Review. French. No abstract available.

PMID:
24649551
[PubMed - indexed for MEDLINE]
9.

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.

McArthur GA, Chapman PB, Robert C, Larkin J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O, Ascierto PA, Garbe C, Testori A, Maio M, Lorigan P, Lebbé C, Jouary T, Schadendorf D, O'Day SJ, Kirkwood JM, Eggermont AM, Dréno B, Sosman JA, Flaherty KT, Yin M, Caro I, Cheng S, Trunzer K, Hauschild A.

Lancet Oncol. 2014 Mar;15(3):323-32. doi: 10.1016/S1470-2045(14)70012-9. Epub 2014 Feb 7.

PMID:
24508103
[PubMed - indexed for MEDLINE]
10.

TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.

Lauden L, Siewiera J, Boukouaci W, Ramgolam K, Mourah S, Lebbe C, Charron D, Aoudjit F, Jabrane-Ferrat N, Al-Daccak R.

J Invest Dermatol. 2014 Jun;134(6):1675-85. doi: 10.1038/jid.2014.20. Epub 2014 Jan 17.

PMID:
24499734
[PubMed - indexed for MEDLINE]
11.

Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trial.

Fennira F, Pagès C, Schneider P, Sidina I, Viguier M, Basset-Seguin N, Madjlessi-Ezra N, Madelaine I, Bagot M, Battistella M, Porcher R, Mourah S, Lebbé C.

Melanoma Res. 2014 Feb;24(1):75-82. doi: 10.1097/CMR.0000000000000034.

PMID:
24241686
[PubMed - in process]
12.

Vemurafenib as a neoadjuvant therapy in advanced melanoma: local tumour control, but no prevention of metastatic relapse.

Tauber M, Pages C, La Selva R, Schneider P, Chardin J, Osio A, Mourah S, Culine S, Vercellino L, Bagot M, Lebbé C.

Eur J Dermatol. 2013 Sep-Oct;23(5):702-3. doi: 10.1684/ejd.2013.2143. No abstract available.

PMID:
24135270
[PubMed - in process]
13.

Human skin carcinoma arising from kidney transplant-derived tumor cells.

Verneuil L, Varna M, Ratajczak P, Leboeuf C, Plassa LF, Elbouchtaoui M, Schneider P, Sandid W, Lebbé C, Peraldi MN, Sigaux F, de Thé H, Janin A.

J Clin Invest. 2013 Sep 3;123(9):3797-801. doi: 10.1172/JCI66721. Epub 2013 Aug 27.

PMID:
23979160
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Angiosarcoma in patients with xeroderma pigmentosum: less aggressive and not so rare?

Karkouche R, Kerob D, Battistella M, Soufir N, Hadj-Rabia S, Bagot M, Lebbé C, Bourrat E.

J Am Acad Dermatol. 2013 Sep;69(3):e142-3. doi: 10.1016/j.jaad.2013.03.011. No abstract available.

PMID:
23957992
[PubMed - indexed for MEDLINE]
15.

Platelet-derived growth factor B induces senescence and transformation in normal human fibroblasts.

Vindrieux D, Gras B, Garcia-Belinchon M, Mourah S, Lebbe C, Augert A, Bernard D.

Aging (Albany NY). 2013 Jul;5(7):531-8.

PMID:
23934686
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.

Ascierto PA, Minor D, Ribas A, Lebbe C, O'Hagan A, Arya N, Guckert M, Schadendorf D, Kefford RF, Grob JJ, Hamid O, Amaravadi R, Simeone E, Wilhelm T, Kim KB, Long GV, Martin AM, Mazumdar J, Goodman VL, Trefzer U.

J Clin Oncol. 2013 Sep 10;31(26):3205-11. doi: 10.1200/JCO.2013.49.8691. Epub 2013 Aug 5.

PMID:
23918947
[PubMed - indexed for MEDLINE]
17.

Kaposi's sarcoma and pregnancy: case report and literature review.

Brunet-Possenti F, Pages C, Rouzier R, Dupin N, Bagot M, Lebbé C.

Dermatology. 2013;226(4):311-4. doi: 10.1159/000349987. Epub 2013 Jul 2. Review.

PMID:
23838298
[PubMed - indexed for MEDLINE]
18.

Treatment patterns and outcomes in patients with advanced melanoma in France.

Bedane C, Leccia MT, Sassolas B, Bregman B, Lebbé C; French investigators of the MELODY study.

Curr Med Res Opin. 2013 Oct;29(10):1297-305. doi: 10.1185/03007995.2013.820693. Epub 2013 Jul 26.

PMID:
23808961
[PubMed - indexed for MEDLINE]
19.

Arterial aneurysm with distal ischemia in a renal allografted patient: beware of angiosarcoma.

Baroudjian B, Battistella M, Mourah S, Hickman G, Pages C, Moulonguet I, Koskas F, Gaudric J, Le Maignan C, Dantal J, Bagot M, Petit A, Lebbe C.

Eur J Dermatol. 2013 Jun 1;23(3):410-1. doi: 10.1684/ejd.2013.2020. No abstract available.

PMID:
23783091
[PubMed - in process]
20.

Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.

Seçkin D, Barete S, Euvrard S, Francès C, Kanitakis J, Geusau A, Del Marmol V, Harwood CA, Proby CM, Ali I, Güleç AT, Durukan E, Lebbé C, Alaibac M, Laffitte E, Cooper S, Bouwes Bavinck JN, Murphy GM, Ferrándiz C, Mørk C, Cetkovská P, Kempf W, Hofbauer GF.

Am J Transplant. 2013 Aug;13(8):2146-53. doi: 10.1111/ajt.12281. Epub 2013 May 29.

PMID:
23718915
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk